Carboranyl Analogues of Mefenamic Acid and Their Biological Evaluation. 2022

Liridona Useini, and Marija Mojić, and Markus Laube, and Peter Lönnecke, and Jonas Dahme, and Menyhárt B Sárosi, and Sanja Mijatović, and Danijela Maksimović-Ivanić, and Jens Pietzsch, and Evamarie Hey-Hawkins
Faculty of Chemistry and Mineralogy, Institute of Inorganic Chemistry, Leipzig University, Johannisallee 29, 04103 Leipzig, Germany.

Mefenamic acid represents a widely used nonsteroidal anti-inflammatory drug (NSAID) to treat the pain of postoperative surgery and heavy menstrual bleeding. Like other NSAIDs, mefenamic acid inhibits the synthesis of prostaglandins by nonselectively blocking cyclooxygenase (COX) isoforms COX-1 and COX-2. For the improved selectivity of the drug and, therefore, reduced related side effects, the carborane analogues of mefenamic acid were evaluated. The ortho-, meta-, and para-carborane derivatives were synthesized in three steps: halogenation of the respective cluster, followed by a Pd-catalyzed B-N coupling and hydrolysis of the nitrile derivatives under acidic conditions. The COX inhibitory activity and cytotoxicity for different cancer cell lines revealed that the carborane analogues have stronger antitumor potential compared to their parent organic compound.

UI MeSH Term Description Entries

Related Publications

Liridona Useini, and Marija Mojić, and Markus Laube, and Peter Lönnecke, and Jonas Dahme, and Menyhárt B Sárosi, and Sanja Mijatović, and Danijela Maksimović-Ivanić, and Jens Pietzsch, and Evamarie Hey-Hawkins
August 2002, Bioorganic & medicinal chemistry letters,
Liridona Useini, and Marija Mojić, and Markus Laube, and Peter Lönnecke, and Jonas Dahme, and Menyhárt B Sárosi, and Sanja Mijatović, and Danijela Maksimović-Ivanić, and Jens Pietzsch, and Evamarie Hey-Hawkins
February 2005, Journal of medicinal chemistry,
Liridona Useini, and Marija Mojić, and Markus Laube, and Peter Lönnecke, and Jonas Dahme, and Menyhárt B Sárosi, and Sanja Mijatović, and Danijela Maksimović-Ivanić, and Jens Pietzsch, and Evamarie Hey-Hawkins
September 2004, Bioorganic & medicinal chemistry,
Liridona Useini, and Marija Mojić, and Markus Laube, and Peter Lönnecke, and Jonas Dahme, and Menyhárt B Sárosi, and Sanja Mijatović, and Danijela Maksimović-Ivanić, and Jens Pietzsch, and Evamarie Hey-Hawkins
February 2016, European journal of medicinal chemistry,
Liridona Useini, and Marija Mojić, and Markus Laube, and Peter Lönnecke, and Jonas Dahme, and Menyhárt B Sárosi, and Sanja Mijatović, and Danijela Maksimović-Ivanić, and Jens Pietzsch, and Evamarie Hey-Hawkins
January 1999, Journal of agricultural and food chemistry,
Liridona Useini, and Marija Mojić, and Markus Laube, and Peter Lönnecke, and Jonas Dahme, and Menyhárt B Sárosi, and Sanja Mijatović, and Danijela Maksimović-Ivanić, and Jens Pietzsch, and Evamarie Hey-Hawkins
January 2009, Current topics in medicinal chemistry,
Liridona Useini, and Marija Mojić, and Markus Laube, and Peter Lönnecke, and Jonas Dahme, and Menyhárt B Sárosi, and Sanja Mijatović, and Danijela Maksimović-Ivanić, and Jens Pietzsch, and Evamarie Hey-Hawkins
January 1986, Acta poloniae pharmaceutica,
Liridona Useini, and Marija Mojić, and Markus Laube, and Peter Lönnecke, and Jonas Dahme, and Menyhárt B Sárosi, and Sanja Mijatović, and Danijela Maksimović-Ivanić, and Jens Pietzsch, and Evamarie Hey-Hawkins
February 1991, Journal of medicinal chemistry,
Liridona Useini, and Marija Mojić, and Markus Laube, and Peter Lönnecke, and Jonas Dahme, and Menyhárt B Sárosi, and Sanja Mijatović, and Danijela Maksimović-Ivanić, and Jens Pietzsch, and Evamarie Hey-Hawkins
April 2020, Molecules (Basel, Switzerland),
Liridona Useini, and Marija Mojić, and Markus Laube, and Peter Lönnecke, and Jonas Dahme, and Menyhárt B Sárosi, and Sanja Mijatović, and Danijela Maksimović-Ivanić, and Jens Pietzsch, and Evamarie Hey-Hawkins
December 1999, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!